Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Osteoporosis.

Lee S Simon1

  • 1Harvard Medical School, Beth Israel Deaconess Hospital, 330 Brookline Avenue, Boston, MA 02215, USA. lsimon@bidmc.harvard.edu

Rheumatic Diseases Clinics of North America
|March 21, 2007
PubMed
Summary
This summary is machine-generated.

Effective therapies can significantly improve the quality of life for individuals with arthritic osteoporosis. This treatable condition requires a strategic approach to manage symptoms and enhance patient well-being.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Validity and utility of a single-item patient-reported measure of treatment-related bother in rheumatoid arthritis: A cross-sectional OMERACT study.

Seminars in arthritis and rheumatism·2026
Same author

The complexity of pain in inflammatory arthropathies beyond pain intensity and impact: An OMERACT initiative.

Seminars in arthritis and rheumatism·2026
Same author

Harm outcomes applicable for most meta-analyses of randomized trials of biomedical interventions: a key concept in clinical epidemiology.

Journal of clinical epidemiology·2026
Same author

Domains for inclusion in a novel Treatment Response Measure for Systemic Lupus Erythematosus (TRM-SLE): results of a modified Delphi study.

Lupus science & medicine·2025
Same author

Slow acting medications for progressive and painful knee osteoarthritis. How do we assess the benefit to risk of these potentially novel therapies?

Osteoarthritis and cartilage open·2024
Same author

Efficacy and safety of a diffusion-based extended-release fluticasone propionate intra-articular injection (EP-104IAR) in knee osteoarthritis (SPRINGBOARD): a 24-week, multicentre, randomised, double-blind, vehicle-controlled, phase 2 trial.

The Lancet. Rheumatology·2024
Same journal

Bridging the Divide in Global Rheumatology.

Rheumatic diseases clinics of North America·2026
Same journal

Foreword.

Rheumatic diseases clinics of North America·2026
Same journal

Pulmonary Complications of Biological Therapies in Inflammatory and Autoimmune Diseases.

Rheumatic diseases clinics of North America·2026
Same journal

Artificial Intelligence and Social Determinants of Health.

Rheumatic diseases clinics of North America·2026
Same journal

Updates in Ultrasound in Rheumatology.

Rheumatic diseases clinics of North America·2026
Same journal

Health Systems Strengthening to Promote Access to Care for Rheumatic and Musculoskeletal Diseases Globally.

Rheumatic diseases clinics of North America·2026
See all related articles

Area of Science:

  • Rheumatology
  • Gerontology
  • Orthopedics

Background:

  • Arthritic osteoporosis presents a complex challenge, impacting bone health and joint function.
  • Co-occurrence of arthritis and osteoporosis requires integrated management strategies.

Purpose of the Study:

  • To highlight the availability of effective therapeutic options for arthritic osteoporosis.
  • To emphasize the importance of a strategic treatment approach for improving patient quality of life.

Main Methods:

  • Literature review of current treatment modalities for arthritic osteoporosis.
  • Analysis of patient outcomes and quality of life indicators.

Main Results:

  • Established therapies demonstrate significant efficacy in managing arthritic osteoporosis.

Related Experiment Videos

  • A well-defined treatment approach is crucial for optimizing patient outcomes.
  • Conclusions:

    • Arthritic osteoporosis is a treatable condition with available effective therapies.
    • Strategic management is key to ensuring an optimal quality of life for affected individuals.